TSG101 抗体
-
- 抗原 See all TSG101 抗体
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This TSG101 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC)
- 产品特性
- Polyclonal Antibody
- 纯化方法
- Affinity purification
- 免疫原
- A synthetic peptide of human TSG101 (NP_006283.1).
- 亚型
- IgG
- Top Product
- Discover our top product TSG101 Primary Antibody
-
-
- 应用备注
- WB 1:500-1:2000 IHC 1:50-1:100
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
- 抗原
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- 别名
- TSG101 (TSG101 产品)
- 背景
- The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.
- 分子量
-
Observed_MW: 44 kDa
Calculated_MW: 31 kDa/43 kDa
- 基因ID
- 7251
- UniProt
- Q99816
-